Jandial, D. A., Brady, W. E., Howell, S. B., Lankes, H. A., Schilder, R. J., Beumer, J. H., . . . Dizon, D. S. (2017). A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study(,). Gynecol Oncol.
Citação norma ChicagoJandial, Danielle A., et al. "A Phase I Pharmacokinetic Study of Intraperitoneal Bortezomib and Carboplatin in Patients With Persistent or Recurrent Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study(,)." Gynecol Oncol 2017.
ציטוט MLAJandial, Danielle A., et al. "A Phase I Pharmacokinetic Study of Intraperitoneal Bortezomib and Carboplatin in Patients With Persistent or Recurrent Ovarian Cancer: An NRG Oncology/Gynecologic Oncology Group Study(,)." Gynecol Oncol 2017.